Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3,182,163
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1,232,073
-
Shares change
-
-2,243,774
-
Total reported value, excl. options
-
$1,538,826
-
Value change
-
-$4,445,404
-
Number of buys
-
2
-
Number of sells
-
22
-
Price
-
$1.42
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q3 2022
As of 30 Sep 2022 Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,232,073 shares of stock of the company.
Largest 8 holders included Erste Asset Management GmbH, Russell Investments Group, Ltd., BARCLAYS PLC, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, Global Trust Asset Management, LLC, China Universal Asset Management Co., Ltd., and US BANCORP \DE\.
This table shows 8 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.